We are a Cambridge-based venture firm backing founders building diagnostic and digital-health infrastructure that actually works — tested against clinical realities before we write a check.
We invest at Seed and Series A in companies building tools that make clinical diagnoses more precise, faster, or accessible — with a recurring emphasis on AI-enabled imaging, computational biology, and health infrastructure.
View all portfolio companies →MD-PhD from Harvard Medical School and MIT. Practiced internal medicine at Mass General before founding Basil Health Ventures in 2019.
Former CMO of a digital-therapeutics company (Series B exit). Chief of Endocrinology at a regional academic hospital. MD Johns Hopkins.
PhD Biomedical Engineering, Duke. Six years leading commercial strategy for pharma and medical-device clients at a Boston life-sciences consultancy.